摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-3-氰基-4,6-二甲基吡啶 | 610279-99-7

中文名称
2-溴-3-氰基-4,6-二甲基吡啶
中文别名
2-溴-4,6-二甲基-3-氰基吡啶
英文名称
2-bromo-4,6-dimethylnicotinonitrile
英文别名
2-Bromo-4,6-dimethylpyridine-3-carbonitrile
2-溴-3-氰基-4,6-二甲基吡啶化学式
CAS
610279-99-7
化学式
C8H7BrN2
mdl
——
分子量
211.061
InChiKey
BBLLODYBGYVNTH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    116-117 °C
  • 沸点:
    326.7±42.0 °C(Predicted)
  • 密度:
    1.52±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    36.7
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-溴-3-氰基-4,6-二甲基吡啶硫酸 、 sodium hydroxide 作用下, 生成 3-氨基-2-溴-4,6-二甲基吡啶
    参考文献:
    名称:
    Anibamine 及其类似物:来自 Aniba citrifolia 的强效抗疟原虫。
    摘要:
    在我们不断寻找具有抗疟原虫活性的新型天然产物的过程中,发现柑橘属植物提取物具有良好的活性,其 IC 50值小于 1.25 μg/mL。经过生物测定定向分离,已知的茚茚生物碱anibamine ( 1 )和新的茚茚生物碱anibamine B( 2 )作为主要生物活性成分被分离出来,抗疟原虫的IC 50值分别为0.170和0.244 μM,对耐药Dd2菌株恶性疟原虫。新香豆素类生物素 A ( 3 )、新的降木脂素 anibignan A ( 5 ) 和六种已知的新木脂素( 7 – 12 )) 也得到了。所有分离出的化合物的结构均基于 1D 和 2D NMR 光谱和质谱数据的分析确定,并从其 ECD 谱中确定了苯丙胺 A ( 5 )的绝对构型。对 28 个阿尼巴胺类似物 ( 13 – 40 )库的评估表明,带四元电荷的类似物的 IC 50值低至 58 nM,而不带电荷的类似物则没有活性或活性显
    DOI:
    10.1021/acs.jnatprod.9b00724
  • 作为产物:
    描述:
    异亚丙基丙二腈氢溴酸乙酸酐 作用下, 以 溶剂黄146甲苯 为溶剂, 反应 3.0h, 生成 2-溴-3-氰基-4,6-二甲基吡啶
    参考文献:
    名称:
    异戊二烯腈胺及其酯类似物对亲电子试剂和亲核试剂的合成及反应活性
    摘要:
    在本文中,我们描述了衍生自亚甲基丙二腈和亚烷基氰基乙酸酯的烯胺的合成和反应性。通过(1)增加醛衍生的亚甲基丙二腈的产率,(2)结合甲硅烷基官能团,和(3)使用其他酰胺缩醛来扩大烯胺环化产生的吡啶的取代方式,来扩大烯胺的范围。另外,描述了由亚甲基丙二腈和亚烷基氰基乙酸酯两者制备α-吡喃酮和多取代的吡啶的方法。
    DOI:
    10.1021/acs.joc.5b01169
点击查看最新优质反应信息

文献信息

  • Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents
    作者:Feng Zhang、Christopher K. Arnatt、Kendra M. Haney、Harrison C. Fang、John E. Bajacan、Amanda C. Richardson、Joy L. Ware、Yan Zhang
    DOI:10.1016/j.ejmech.2012.07.049
    日期:2012.9
    Anibamine, a novel pyridine quaternary alkaloid isolated from Aniba sp., was found to effectively compete with 125I-gp120 in binding to the chemokine receptor CCR5, with an IC50 = 1 μM. Anibamine is the first natural product reported as a CCR5 antagonist, and thus provides a novel structural skeleton unique from other lead compounds that have generally been identified from high-throughput screening efforts
    最近的研究表明,CCR5趋化因子受体可能是治疗前列腺癌的潜在靶标。因此,CCR5拮抗剂的开发可以提供新颖的前列腺癌治疗方法。发现Anibamine是一种从Aniba sp。分离的新型吡啶季生物碱,其与趋化因子受体CCR5的结合可有效与125 I-gp120竞争,其IC 50为50 = 1μM。茴香胺是第一个被报道为CCR5拮抗剂的天然产物,因此提供了一种不同于其他先导化合物的新颖结构骨架,而这些先导化合物通常是从高通量筛选工作中鉴定出来的。为了改善先导化合物的结构并提高阿尼巴胺衍生物作为潜在的抗前列腺癌药物的治疗指数,在这项工作的结构-活性关系研究中采用了“解构-重建-精制”的方法。在这里,我们报告阿尼巴明和17类似物的设计,合成和抗前列腺癌活性。从结果在体外和体内在此描述的研究表明,这类化合物有潜力提供新颖的引线作为抗前列腺癌试剂。
  • Magnesiation of Pyridine <i>N</i>-Oxides via Iodine or Bromine−Magnesium Exchange: A Useful Tool for Functionalizing Pyridine <i>N</i>-Oxides
    作者:Xin-Fang Duan、Zi-Qian Ma、Fang Zhang、Zhan-Bin Zhang
    DOI:10.1021/jo802172f
    日期:2009.1.16
    Iodo- or 2-bromopyridine N-oxides were readily magnesiated with i-PrMgCl·LiCl via the iodine or bromine−magnesium exchange. The bromine adjacent to pyridine N-oxide (at the 2- or 6-position) can be regioselectively magnesiated in the presence of other position substituted halogens. This method was tested in various substituted pyridine N-oxide systems, and has been successfully applied to the total
    碘或2-溴吡啶N-氧化物很容易通过碘或溴-镁交换与i- PrMgCl·LiCl镁化。可以在其他位置取代的卤素存在下,将与吡啶N-氧化物相邻的溴(在2-或6-位)进行区域选择性氧化。该方法已在各种取代的吡啶N-氧化物系统中进行了测试,已成功地应用于铜霉素E和A的全合成。
  • [EN] COMPOUNDS COMPRISING A 3-PYRIDINOL OR 5-PYRIMIDINOL RING HAVING AN ORGANOSELENO OR ORGANOTELLURO SUBSTITUENT FOR USE AS ANTIOXIDANTS<br/>[FR] COMPOSÉS COMPRENANT UN NOYAU 3-PYRIDINOL OU 5-PYRIMIDINOL À SUBSTITUANT ORGANOSÉLÉNO OU ORGANOTELLURO UTILISÉS COMME ANTI-OXYDANTS
    申请人:KAROLINSKA INST INNOVATIONS AB
    公开号:WO2009144253A1
    公开(公告)日:2009-12-03
    Compounds comprising a 3-pyridinol or 5-pyrimidinol ring carrying an organoseleno- or organotelluro- substituent on the pyridine or pyrimidine ring, exhibit useful antioxidant properties. The compounds may for example be in accordance with the following formula (I) as defined herein. Catalytic chain-breaking and hydroperoxide decomposing antioxidant properties are also disclosed. Furthermore the compounds may be used in combination with a reducing agent. The compounds are useful for the stabilization of man-made and natural materials, or for the prevention or treatment of disorders caused by or involving free radical-mediated or oxidative tissue damage.
    含有3-吡啶醇或5-嘧啶醇环,在吡啶或嘧啶环上带有有机硒或有机碲取代基团的化合物,表现出有用的抗氧化性能。这些化合物可能符合以下定义的化学式(I)。还披露了催化链断裂和过氧化物分解抗氧化性能。此外,这些化合物可以与还原剂结合使用。这些化合物可用于稳定人造和天然材料,或用于预防或治疗由自由基介导或氧化组织损伤引起的疾病。
  • Catalytic Chain-Breaking Pyridinol Antioxidants
    作者:Sangit Kumar、Henrik Johansson、Takahiro Kanda、Lars Engman、Thomas Müller、Helena Bergenudd、Mats Jonsson、Gian Franco Pedulli、Riccardo Amorati、Luca Valgimigli
    DOI:10.1021/jo902226t
    日期:2010.2.5
    The synthesis of 3-pyridinols carrying alkyltelluro, alkylseleno, and alkylthio groups is described together with a detailed kinetic, thermodynamic, and mechanistic Study of their antioxidant activity. When assayed for their capacity to inhibit azo-initiated peroxidation of linoleic acid in a water/chlorobenzene two-phase system, tellurium-containing 3-pyridinols were readily regenerable by N-acetylcysteine contained in the aqueous phase. The best inhibitors quenched peroxyl radicals more efficiently than alpha-tocopherol, and the duration of inhibition was limited only by the availability of the thiol reducing agent. fn homogeneous phase, inhibition of styrene autoxidation absolute rate constants k(inh) for quenching of peroxyl radical were as large as 1 x 10(7) M-1 s(-1), thus Outperforming the best phenolic antioxidants including alpha-tocopherol. Tellurium-containing 3-pyridinols could be quantitatively regenerated in homogeneous phase by N-tert-butoxycarbonyl cysteine methyl ester, a lipid-soluble analogue of N-acetylcysteine. In the presence of an excess of the thiol, a catalytic mode of action was observed, similar to the one in the two-phase system. Overall, compounds bearing the alkyltelluro moiety ortho to the OH group were much more effective antioxidants than the corresponding para isomers. The origin of the high reactivity of these compounds was explored using pulse-radiolysis thermodynamic measurements, and a mechanism for their unusual antioxidant activity was proposed. The tellurium-containing 3-pyridinols were also found to catalyze reduction of hydrogen peroxide in the presence of thiol reducing agents, thereby acting as multifunctional (preventive and chain-breaking) catalytic antioxidants.
  • The potential role of anibamine, a natural product CCR5 antagonist, and its analogues as leads toward development of anti-ovarian cancer agents
    作者:Yan Zhang、Christopher K. Arnatt、Feng Zhang、Jiannan Wang、Kendra M. Haney、Xianjun Fang
    DOI:10.1016/j.bmcl.2012.05.127
    日期:2012.8
    Chemokines and their receptors play important roles in the development of primary tumors and their metastases. Particularly CC chemokine receptor 5 (CCR5) and its ligand CC chemokine ligand 5 (CCL5/RANTES) seem to be critical in proliferation and invasion of ovarian cancer, the leading cause of death from gynecological malignancies in the United States. Anibamine, the first natural product CCR5 antagonist, and its analogues were examined for their effects on proliferation of the OVCAR-3 ovarian cancer cells in order to validate their candidacy as leads to develop novel anti-ovarian cancer agents. Acting as CCR5 antagonists, anibamine and its analogues significantly suppressed CCL5-induced intracellular Ca2+ flux. The compounds also inhibited the proliferation of OVCAR-3 at micromolar to submicromolar range. Moreover, anibamine and several analogues did not show significant cytotoxicity in NIH 3T3 cells at concentrations up to 20 mu M. Based on these results, anibamine and one of its synthetic analogues were defined as potential leads to develop novel agents against ovarian cancer. Published by Elsevier Ltd.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-